|
ZNRF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.955200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.908400E-01 |
| Normal-vs-Stage2 |
9.968000E-01 |
| Normal-vs-Stage3 |
3.855800E-03 |
| Normal-vs-Stage4 |
2.741700E-02 |
| Stage1-vs-Stage2 |
6.307800E-01 |
| Stage1-vs-Stage3 |
1.839990E-02 |
| Stage1-vs-Stage4 |
5.712000E-02 |
| Stage2-vs-Stage3 |
4.540000E-02 |
| Stage2-vs-Stage4 |
9.840400E-02 |
| Stage3-vs-Stage4 |
8.169800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.390400E-02 |
| Normal-vs-AfricanAmerican |
7.274200E-01 |
| Normal-vs-Asian |
4.371000E-01 |
| Caucasian-vs-AfricanAmerican |
6.375600E-02 |
| Caucasian-vs-Asian |
6.681200E-01 |
| AfricanAmerican-vs-Asian |
2.889000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.629000E-01 |
| Normal-vs-Female |
2.000000E-01 |
| Male-vs-Female |
6.378200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.412220E-01 |
| Normal-vs-Extreme_Weight |
2.461000E-01 |
| Normal-vs-Obese |
2.179400E-01 |
| Normal-vs-Extreme_Obese |
7.403400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.532000E-01 |
| Normal_Weight-vs-Obese |
5.863600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.884000E-01 |
| Extreme_Weight-vs-Obese |
9.625000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.918400E-01 |
| Obese-vs-Extreme_Obese |
3.125200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.699600E-03 |
| Normal-vs-Age(41-60Yrs) |
8.682800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.337900E-02 |
| Normal-vs-Age(81-100Yrs) |
6.760400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.682800E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.259950E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.568400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.330000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.857800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.302400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.959800E-01 |
| Normal-VS-Type2 PRCC |
4.328300E-02 |
| Normal-VS-KIRP CIMP |
3.424600E-04 |
| Normal-VS-Unclassified PRCC |
2.314200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.555950E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.636150E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.804140E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.394230E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.464200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.647570E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.709700E-02 |
| Normal-vs-N1 |
4.753900E-04 |
| Normal-vs-N2 |
1.518410E-02 |
| N0-vs-N1 |
1.001800E-01 |
| N0-vs-N2 |
2.787400E-01 |
| N1-vs-N2 |
4.372600E-01 |
|
|
